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Abstract
Objectives Systematic review to determine any association
between imaging features of idiopathic mesenteric
panniculitis (MP) and subsequent malignancy.
Methods Two researchers searched primary literature inde-
pendently for imaging studies of MP. They extracted data
focusing on methodology for unbiased patient accrual and
capability to determine a link between MP and subsequent
malignancy. They noted imaging features of MP. Data were
accrued and meta-analysis intended.
Results Fourteen of 675 articles were eligible; 1,226 patients.
Only three (21 %) accrued patients prospectively. Twelve
(86 %) studies described CT features. Follow-up varied wide-
ly; 1 month to 8 years. Prevalence of MP was influenced by
accrual: 0.2 % for keyword search versus 1.7 % for consecu-
tive series. Accrual bias affected nine (64 %) studies. 458
(38 %) of 1,209 patients had malignancy at accrual but varied
widely (8–89 %), preventing meta-analysis. Sixty (6.4 %) of
933 patients developed new malignancy subsequently, also
varying widely (0–11 %). Of just four studies that determined
the proportion of unselected, consecutive patients with MP
developing subsequent malignancy, three were retrospective
and the fourth excluded patients with lymphadenopathy, likely
excluding patients with MP.
Conclusion Studies were heterogeneous, with biased accrual.
No available study can determine an association between MP
and subsequent malignancy with certainty.
Key Points
• Our systematic review of mesenteric panniculitis found that
imaging studies were biased.
• Spectrum and recruitment bias was largely due to retrospec-
tive study designs.
• No study could confirm a certain link between mesenteric
panniculitis and subsequent malignancy.
• Excessive methodological heterogeneity precluded meaning-
ful meta-analysis.
• High-quality research linking mesenteric panniculitis imag-
ing features and subsequent malignancy is needed.
Keywords Panniculitis . Panniculitis, peritoneal . Sclerosing
mesenteritis . Helical computed tomography . Computed
tomography, spiral
Introduction
Mesenteric panniculitis (MP) [1] describes inflammation
of mesenteric fat and is manifest on CT scanning as a
circumscribed region of increased mesenteric density, of-
ten exhibiting a mass-like effect, containing several lymph
nodes, and engulfing mesenteric vessels [2, 3]. MP is
known by a variety of alternative terms including ‘mes-
enteric lipodystrophy’ [4], ‘liposclerotic mesenteritis’ [5]
and ‘misty mesentery’ [6, 7]. The latter term includes
entities such as ‘sclerosing mesenteritis’ [8] and ‘retractile
mesenteritis’ [9]. Such varied terminology reflects confu-
sion regarding the precise definition of MP.
An association between MP and development of sub-
sequent malignancy has been raised [10, 11], suggesting
MP is an important finding. Alternatively, others state
there is no association between MP and malignancy
[12]. Lack of consensus regarding the clinical significance
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of MP thus presents radiologists with a diagnostic dilem-
ma because MP is encountered frequently as an appar-
ently incidental finding on cross-sectional imaging, usu-
ally abdominopelvic CT. Furthermore, referring clini-
cians will usually be unfamiliar with MP and will there-
fore look to the reporting radiologist for management
guidance. To attempt to clarify the significance of MP
in the face of apparently contradictory evidence we per-
formed a systematic review of available medical litera-
ture, focusing on the cross-sectional imaging findings of
MP and any association with development of subse-
quent malignancy.
Methods
Ethical approval is not required by our institution for second-
ary research using primary literature.
Data sources and search strategy
We wished to identify primary studies describing imaging
findings of MP. To be as inclusive as possible we used all of
the following terms: mesenteric panniculitis, mesenteritis,
sclerosing panniculitis, sclerosing mesenteritis, misty mesen-
tery, retractile mesenteritis, liposclerotic mesenteritis and mes-
enteric lipodystrophy. We combined terms in the following
search string, to identify studies describing peritoneal
manifestations:
((("mesentery"[MeSH Terms] OR "mesentery"[All
Fields] OR "mesenteric"[All Fields]) OR sclerosing[All
Fields] OR misty[All Fields] OR liposclerotic[All Fields]
OR retractile[All Fields] OR ("peritoneum"[MeSH
Te rm s ] OR "p e r i t o n e um" [A l l F i e l d s ] OR
"peritoneal"[All Fields])) AND (mesenteritis[All Fields]
OR ("panniculitis"[MeSH Terms] OR "panniculitis"[All
Fields]) OR ("lipodystrophy"[MeSH Terms] OR
"lipodystrophy"[All Fields]))) OR (misty[All Fields]
AND ("mesentery"[MeSH Terms] OR "mesentery"[All
Fields]))
This string was then used to search the USNational Library
of Medicine PUBMED journal citation database (http://www.
ncbi.nlm.nih.gov/pubmed). Results were then limited to
humans (using: AND "humans"[MeSH Terms]), limited to
English language (using: AND English[lang]), and case
reports were excluded (using: NOT Case Reports[ptyp]). We
used the systematic review filter (AND pmh_sr[sb]) to
identify prior systematic reviews and reviewed the initial
search (i.e. excluding filters) to identify any articles
excluded incorrectly.
Two radiologists performed the search, one (SH) with
13 years’ experience of systematic review design, extraction
and analysis, the other (AP) with 3 years’ experience.
Disagreement was resolved face-to-face.
Inclusion/exclusion criteria for primary studies
The electronic abstract of identified studies was read and the
following exclusion criteria applied: We excluded articles
without a focus on idiopathic MP. For example, we excluded
IgG disease, post-renal transplant panniculitis, Nasu-Hakola
disease and cutaneous panniculitis. Because we wished to
investigate any association between MP and subsequent ma-
lignancy, we excluded studies exclusively recruiting patients
known to have abdominopelvic malignancy or to have re-
ceived abdominopelvic irradiation. Studies combining pa-
tients with and withoutmalignancywere included.We exclud-
ed studies not reporting cross-sectional imaging data (we in-
cluded ultrasound). Specifically, we excluded articles pub-
lished before the introduction of CT scanning (i.e. pre 1973).
We excluded narrative reviews and letters/correspondence.
We excluded case reports and small cases series since these
would not contribute sufficient unbiased data able to answer
our research question. After consensus, we defined ‘small’ as
ten or fewer cases recruited from a single centre. We defined
single centre as a single hospital or single hospital grouping
because we would expect such groupings to exhibit correlated
patients and/or practice.
If no electronic abstract were available, or if a confident
decision regarding exclusion was not possible, the full article
was retrieved online and read. An excluded study log was
kept, recording the single most relevant reason for exclusion
(although we anticipated some articles would be rejected for
multiple reasons), and passed to the other authors for review.
Data extraction
The following data were extracted from full articles meeting
inclusion criteria by the two radiologists performing the
search (working independently), into a database (Excel for
Mac 2011, Microsoft, Redmond WA): We noted sample size,
gender and age distribution of participants, whether the study
was single or multicentre, and whether accrual was prospec-
tive or retrospective. We noted the proportion of patients with
malignancy and/or a history of abdominopelvic surgery at
accrual, the proportion who were symptomatic, the length of
follow-up and the proportion developing new malignancy
during follow-up, and its nature. We assessed whether patient
selection was subject to spectrum bias (e.g. by using a retro-
spective keyword search) and whether the study design
allowed estimation of the proportion of patients without ma-
lignancy who then developed malignancy subsequent to their
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diagnosis of MP. We noted the imaging test used for diagnosis
ofMP andwhether an independent reference test was adopted.
Regarding CT features of MP, we noted the following eight
features: Proportion of patients exhibiting increased mesenter-
ic density; whether a mesenteric ‘mass’ was present; linear
dimensions of any mass; whether a ‘capsule’ was present
[13]; the proportion of patients with lymphadenopathy; the
largest nodal diameter; diameter range; proportion of patients
with a nodal ‘halo’ [13].
Analysis
Tabulated data were described by median and range (or mean
where this was presented in the primary article). We wished to
perform a meta-analysis to obtain a point-estimate describing
the proportion of patients withMPwho developed subsequent
malignancy. Ultimately, meta-analysis was prevented by the
small number of studies retrieved that presented adequate da-
ta, combined with excessive methodological heterogeneity,
meaning that any point estimate would lack precision. We
wrote our report noting PRISMA guidelines for transparent
reporting of systematic reviews [14].
Results
The PUBMED search was performed 21 April 2015 and
yielded 675 potential articles. Limiting to human studies ex-
cluded 96, limiting to English language excluded a further 189
and excluding case reports excluded a further 265, leaving 125
articles. Application of the exclusion criteria to the electronic
abstract excluded 111 of these, leaving 14 articles included in
the systematic review. The PRISMA flow chart is shown in
Fig. 1.
The exclusion log recorded that of the 111 excluded arti-
cles, 65 were primarily because they did not describe MP, 17
were narrative reviews, two were letters, nine described no
cross-sectional imaging, five were ‘small’ by our definition,
one recruited malignancy exclusively and 12 were published
prior to 1973. We found no systematic reviews.
Study characteristics and design
Characteristics for included studies are described in Table 1.
Overall, included studies contributed 1,226 patients with MP,
with an individual range between 17 and 359. Median patient
age was 62 years, range 11–98. Of studies stating gender, 603
(70 %) patients were male and 264 (30 %) were female.
Females predominated in a single study [17]. Only three
(21 %) studies accrued patients prospectively [1, 17, 20],
whereas ten were retrospective (71 %). One combined retro-
spective and prospective accrual [15]. None were genuinely
multicentre.
Twelve (86 %) studies focused on CT features of MP. One
described positron emission tomography (PET)-CT [18] while
another described ultrasound [19]. Diagnosis of MP was
established histologically in all patients in two studies [8,
15]. Histology was used in an unspecified proportion of pa-
tients in four other studies [10, 17, 18, 20], but most relied on
CT/imaging features themselves to establish the diagnosis. In
studies describing a follow-up period, this ranged widely,
varying from less than 1 month [20] to 8 years [19] for indi-
vidual patients.
Seven studies stated the total population of cases from
which cases of MP were drawn, allowing calculation of prev-
alence of abnormality. Two [11, 12] of these used a retrospec-
tive keyword search to identify patients whereas five [1–3, 17,
18] interrogated a consecutive patient series. Overall, preva-
lence of MP for studies using a keyword search was 0.2 %
(195 of 87,017 patients), compared to 1.7 % (313 of 18,389)
for studies using consecutive series.
We concluded that spectrum bias influencing patient accru-
al was potentially present in at least nine (64 %) of the 14
studies. This was mostly because accrual was retrospective
and relied upon identifying patients via a keyword search of
the radiology information system. This approach will miss
patients if the precise term does not appear in the report or
those in whom the condition is not reported [6, 8, 10–12, 16,
19]. One study only recruited patients with a histological di-
agnosis, thus biasing accrual towards severe cases [15],
whereas another recruited only patients having PET-CT, in-
ducing bias towards patients with malignancy [18]. One study
used a case-control design, matching MP patients with two
age- and gender-matched controls [12]. Five studies reduced
selection bias by reporting consecutive case series. Two [2, 3]
of these were retrospective and three [1, 17, 20] were prospec-
tive. Unfortunately, the prospective studies lacked details of
subsequent malignancy[20], were hampered by incomplete
follow-up [17] or were restricted to patients having subse-
quent CT [1]. Overall, we concluded there were just four stud-
ies whose design allowed the reader to determine the propor-
tion of an unselected consecutive group of patients with MP
who developed malignancy subsequently. However, three of
these were retrospective and potentially subject to accrual bias
from keyword searching [6, 10, 19]. This left just one study in
which consecutive unselected patients were analysed, but this
was retrospective, single centre and had excluded any patients
with a nodal diameter in excess of 1 cm, a procedure likely to
exclude some patients with idiopathic MP [3].
Associated symptoms and malignancy
Only eight (57 %) studies described the proportion of symp-
tomatic patients: 710 (79 %) of 894 patients were symptom-
atic, with individual proportions ranging from 23 % [19] to
100% [8, 10, 17, 21]. ‘Abdominal pain’was themost frequent
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description reported, occurring in a median of 51% of patients
in whom symptoms were reported (range 6–83 %). Other
symptomswere reported too variably to summate but included
abdominal distension and change in bowel habit.
Fig. 1 PRISMA flow chart for
the systematic review
Table 1 Characteristics of included studies and patients
Individual study Patient accrual Multi- or single-centre No. of patients Male/female Mean age (range)
Akram [15] Mixed Single 92 64/28 64.5 (55–72)
Badet [16] Retrospective Single 158 121/37 63 (27–98)
Canygit [2] Retrospective Single 51 35/16 56.2 (33–78)
Corwin [6] Retrospective Single 37 22/15 62.6 (25–90)
Coulier [1] Prospective Single 48 29/19 not stated
Daskalogiannaki [17] Prospective Single 49 17/32 62 (27–84)
Gogebakan [12] Retrospective Single 77 59/18 65.5 (SD 11.9)
Nakatani [18] Retrospective Single 71 47/24 65 (39-88)
Roson [19] Retrospective Single 26 18/8 69 (35–85)
Sabate [8] Retrospective Single 17 14/3 52 (11–84)
Seo [20] Prospective Single 29 19/10 57 (18–85)
Smith [10] Retrospective Single group 359 not stated 66.9 (19–97)
van Putte-Katier [3] Retrospective Single 94 66/28 66.6 (SD 11.2)
Wilkes [11] Retrospective Single group 118 92/26 61 (20–88)
SD standard deviation
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Nine studies described surgical history but five of these
either did not detail the specific procedure or did not quantify
them. Of those detailing surgical history, 270 (43 %) of 634
patients had prior surgery; the individual proportion ranged
from 31 % [19] to 57 % [17]. The most common procedures
were cholecystectomy or appendectomy.
Thirteen studies described the proportion of patients with
known malignancy at the time of MP diagnosis. Of 1,209
patients overall, 458 (38 %) had known malignancy. This
proportion ranged widely for individual studies; from 8 %
[6] to 89 % [18], precluding meta-analysis. Of these 458,
115 (25 %) were lymphomas and 343 (75 %) were other
malignancies. Again, the proportion of patients with lympho-
ma varied widely for individual studies, from 3% [15] to 34%
[18]. In eight studies it was possible to calculate the proportion
of patients who developed a new malignancy subsequent to
diagnosis of MP: This occurred in 60 (6.4 %) of a total 933
patients. Of these 60 malignancies, 20 (33 %) were lympho-
mas and 40 (67 %) were other malignancies. The proportion
of patients developing a newmalignancy varied from 0% [17,
19] to 11 % [11] for individual studies.
Imaging features of mesenteric panniculitis
We investigated eight CT features ofMP but we were unable to
extract all of these from any individual article, indicating that
description of CT features was generally poor. Of the nine
studies that described whether patients had increased mesenter-
ic density on CTscanning, 556 (90%) of 617 patients displayed
this feature. Indeed, eight studies stipulated this feature as an
inclusion criterion [1–3, 6, 8, 16–18]. A discrete ‘mass’ was
described in 473 (93 %) of the 509 patients in whom this was
evaluated. Again, several studies stipulated this feature as an
inclusion criterion [1–3, 8, 16, 17]. Only four (27 %) studies
documented the dimension of any mass, reporting means of
40 mm (range 20–74) [20], 50 mm (27–108 mm) [2], 95 mm
(range 71–152 mm) [17] and 95 mm (standard deviation
19 mm) [3], respectively. Six studies [1–3, 8, 16, 17] stated
whether a hyperattenuating rim appeared to encapsulate the
region of mesenteric panniculitis, this feature being present in
239 (57 %) of the 417 patients evaluated. The individual pro-
portion ranged between 35 % [8] and 59 % [16, 17].
Given that lymph nodes are a prominent feature of mesen-
teric panniculitis [13], the description of nodal imaging char-
acteristics was surprisingly sparse overall. Some studies de-
scribed ‘bulky lymphadenopathy’ but did not define the nodal
diameter or other characteristics necessary to satisfy this def-
inition [20]. Others defined lymphadenopathy as a diameter
greater than 1 cm and noted the proportion of patients exceed-
ing this threshold, but gave no other details; for example the
mean diameter and range of nodal size for these patients or for
patients overall [8]. Conversely, one study excluded patients
with nodes measuring 1 cm or greater, believing this to
exclude the diagnosis of mesenteric panniculitis [3]. The larg-
est nodal diameter could be determined in only four (27 %)
studies, being 13 mm [2], 19 mm [1], 35 mm [6] and 41 mm
[12], respectively. Ultimately, only two studies described
mean nodal diameter and the range across all patients, this
being 6.4 mm (range 3.1–13 mm) [2] and 8.7 mm (range 3–
35 mm) [6], respectively. Seven studies [1–3, 8, 16, 17, 20]
stated whether lymph nodes were surrounded by a
hypoattenuating ‘halo’ within the region of mesenteric
panniculitis, a feature present in 284 (64%) of the 446 patients
in whom this was assessed. The individual proportion ranged
widely between 7 % [20] and 94 % [3].
Discussion
Mesenteric panniculitis presents a clinical problem when dis-
covered incidentally in patients not known to have an under-
lying cause, in which case it can be termed ‘idiopathic’.
Because an association with subsequent malignancy has been
described, patients are frequently referred for follow-up imag-
ing on multiple occasions over a prolonged period. The pre-
cise extent to which this happens is unknown currently, but
anecdotal evidence suggests it is substantial, not least because
features of MP often persist. We were prompted to perform
our systematic review because this set of circumstances had
arisen on multiple occasions during our hospital multidisci-
plinary meetings. In particular, we were interested in assessing
primary research evidence linking apparently idiopathic MP
with subsequent malignancy.
We found that 38 % of reported patients had known under-
lying malignancy at the timeMPwas diagnosed. In such cases
MP assumes a minor role, since attention will focus on known
malignancy. Studies that include patients with known malig-
nancy will confound any attempt to determine the clinical
course of patients with incidental MP. The true incidence of
MP is difficult to determine since this requires assessment of a
consecutive, unselected group of patients by radiologists
aware of and able to diagnose the condition. Most studies
applied a search term to a radiology information system retro-
spectively, potentially missing patients whose report did not
contain the term. One study [3] used a retrospective cohort
design to interrogate consecutive scans, which eliminates in-
clusion bias, but then excluded patients with lymphadenopa-
thy, which will likely eliminate some patients with idiopathic
MP. A minority did report consecutive, prospective cases but
were often personal series hampered by small size and single-
centre accrual. We found the prevalence of MP was just 0.2 %
for studies using a retrospective keyword search versus 1.7 %
for studies interpreting a consecutive series. These data sug-
gest that keyword searches miss most patents with MP.
Severe manifestations of MP do appear to exist, but the
overall proportion of patients with proven histology was very
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small, suggesting the largemajority do not come to surgery for
MP alone. Stipulating histological proof of MP would create
substantial spectrum bias towards severe disease, unrepresen-
tative of most patients with MP. While, strictly speaking, the
true prevalence of idiopathic MP can only be ascertained by
examining asymptomatic patients as well, the clinical problem
turns on imaged patients who then present a clinical dilemma.
Accordingly, the majority of studies used CT scanning as the
reference standard for diagnosis. Although this suggests in-
corporation bias, we do not believe this is a major issue be-
cause the clinical issue revolves around these very
same patients. CTscans on whichMP is diagnosed are usually
performed to investigate abdominopelvic symptoms, so we
would expect symptom prevalence to appear high: Overall,
79 % had symptoms. However, it is unclear what proportion
of idiopathic MP is symptomatic. For example, many patients
had underlying malignancy and/or symptoms that may be un-
related to MP. Our anecdotal experience in patients without
malignancy suggests that symptoms precipitating the initial
scan often subside but features of MP persist across subse-
quent imaging. Unfortunately, individual studies reported in-
sufficient detail for us to resolve these issues. Ultimately, we
concluded that the incidence of idiopathic MP is unknown
with precision currently.
Our primary research question asked what proportion of
patients with idiopathic MP then develop subsequent malig-
nancy? However, many studies did not report a follow-up
period, or this was relatively short. Unfortunately, we conclud-
ed that just four studies allowed the reader to determine the
proportion of an unselected consecutive group of MP patients
who developed malignancy subsequently. Ultimately, because
three of these were potentially subject to accrual bias and the
fourth had excluded patients with lymphadenopathy in excess
of 1 cm, we concluded that no study in the existing literature
could answer our research question using sound methodology.
Our intention to perform meta-analysis was frustrated.
Furthermore, we found no prior systematic reviews.
Ultimately, we do not know whether patients with apparently
idiopathic MP are at greater risk of subsequent malignancy
than the age- and sex-matched general population, a conclu-
sion also reached by a recent commentary [22].
A research study to answer this question should recruit
consecutive, unselected patients prospectively, to reduce in-
clusion bias. Patients should be representative of those under-
going abdominopelvic CT for all indications since CT is the
modality usually precipitating the problem. Observers should
be radiologists familiar with and able to diagnose MP, and
precise CT definitions for the diagnosis should be stipulated
(which was largely lacking from the papers we identified).
Patients would need to be characterised in detail, to identify
and exclude those with existing or undiagnosed malignancy at
the time of imaging, and to clarify symptoms and their natural
history. Follow-up should be sufficient to establish clinical
outcome with precision, and should extend several years to
determine any link with subsequent malignancy, likely via
cancer registries so as to maximize data capture and to allow
comparison with age- and sex-matched controls. A
multicentre setting would be necessary both to achieve suffi-
cient power and to enhance generalisability of results.
Imaging findings should be correlated with clinical outcome.
For example, we attempted to extract eight individual CT
features of MP but could not do this completely for any indi-
vidual article. Indeed, several studies failed to report the im-
aging features of MP or characterise lymphadenopathy.
Description of the CT features of MP is therefore generally
poor, which hinders any critical discussion of the precise im-
aging features necessary for diagnosis.
In summary, we performed a systematic review to deter-
mine any association between imaging findings of idiopathic
MP and development of subsequent malignancy. Overall,
studies were heterogeneous and used varying methodologies
to identify patients, resulting in biased accrual. Frequently,
patients and their clinical follow-up were characterised insuf-
ficiently to answer our research question. We could not per-
form meta-analysis. Any association between imaging fea-
tures of idiopathic MP and development of subsequent malig-
nancy remains unknown presently. The available literature
currently lacks studies that are methodologically sound
enough to answer this important question with precision.
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